Valuation: PharmaEssentia Corporation

Market Cap 53TCr 1.65TCr 1.44TCr 1.33TCr 1.23TCr 2.33TCr 1,57100Cr 2.37TCr 16TCr 6.23TCr 77TCr 6.18TCr 6.04TCr 2,67200Cr P/E 2026 *
49.3x
P/E 2027 * 35.9x
Enterprise Value 50TCr 1.56TCr 1.37TCr 1.26TCr 1.17TCr 2.21TCr 1,49200Cr 2.25TCr 15TCr 5.92TCr 73TCr 5.87TCr 5.74TCr 2,53800Cr EV / Sales 2026 *
20.1x
EV / Sales 2027 * 14.3x
Free-Float
78.15%
Yield 2026 *
0.07%
Yield 2027 * 0.11%
1 day-6.84%
1 week+4.81%
Current month+6.37%
1 month+53.93%
3 months+119.97%
6 months+175.18%
Current year+203.28%
1 week 1,244.05
Extreme 1244.0526
1,415.34
1 month 832.07
Extreme 832.0729
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-6.84%+4.81%+201.88%+348.11% 1.77TCr
-0.38%+0.40%+71.69%+128.83% 5.67TCr
+4.91%-3.30%+71.97%+92.14% 5.13TCr
+1.48%+5.97%+22.59%+479.71% 2.53TCr
-0.59%-4.68%-16.82%-13.45% 2.37TCr
+3.93%+7.11%+44.20%-1.96% 1.87TCr
+2.01%+7.22%+41.55%-24.93% 1.77TCr
-0.92%+8.90%+38.48% - 1.43TCr
+1.76%+2.24%+29.57%+199.42% 1.41TCr
-0.95%+6.04%+81.47%+154.45% 1.3TCr
Average +0.48%+4.10%+58.66%+151.37% 2.52TCr
Weighted average by Cap. +0.99%+2.56%+59.80%+144.19%

Financials

2026 *2027 *
Net sales 2.51TCr 78Cr 68Cr 63Cr 58Cr 110.32Cr 7.43TCr 112.17Cr 752.32Cr 294.91Cr 3.65TCr 292.34Cr 286.02Cr 13TCr 3.46TCr 107.38Cr 94Cr 87Cr 80Cr 152.12Cr 10TCr 154.67Cr 1.04TCr 406.65Cr 5.03TCr 403.1Cr 394.39Cr 17TCr
Net income 1.09TCr 34Cr 29Cr 27Cr 25Cr 48Cr 3.22TCr 49Cr 325.75Cr 127.69Cr 1.58TCr 126.58Cr 123.84Cr 5.47TCr 1.5TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.44TCr 67Cr 449.31Cr 176.13Cr 2.18TCr 174.6Cr 170.82Cr 7.55TCr
Net Debt -2.65TCr -82Cr -72Cr -66Cr -62Cr -116.73Cr -7.86TCr -118.68Cr -796.02Cr -312.04Cr -3.86TCr -309.32Cr -302.63Cr -13TCr -3.47TCr -107.88Cr -94Cr -87Cr -81Cr -152.84Cr -10TCr -155.39Cr -1.04TCr -408.55Cr -5.06TCr -404.99Cr -396.23Cr -18TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
09/26/09 NT$1,285.00 -6.84% 67,11,957
08/26/08 NT$1,379.28 +2.34% 47,71,223
07/26/07 NT$1,347.72 +3.46% 39,59,953
06/26/06 NT$1,302.65 +3.58% 29,09,866
03/26/03 NT$1,257.57 0.00% 35,56,029
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,285.00TWD
Average target price
1,049.67TWD
Spread / Average Target
-18.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock